Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hematology
Chemotherapy
Questions discussed in this category
Does the presence of asparaginase antibodies on Granger Genetics testing indicate need to switch asparaginase formulations?
1 Answer available
What is your approach to management of chronic neutropenia in a patient with Sjogren’s who was recently diagnosed with metastatic endometrial cancer and plans to start chemotherapy?
ANC <500
1 Answer available
When using daratumumab in the setting of post-transplant red cell aplasia or post-transplant immune-mediated cytopenias, do you hold the drug for certain ANC parameters?
1 Answer available
17602
17182
13630
Papers discussed in this category
Mediterranean journal of rheumatology, 2022 Mar 31
Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren's Syndrome.
Pediatric blood & cancer, 2015-06
Clinical application of asparaginase activity levels following treatment with pegaspargase.
Leukemia & lymphoma, 2018-08
Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.
Haematologica, 2016 Mar
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation.
Related Topics in Hematology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers